Survodutide 10mg – ≥99% pure, lyophilized peptide in sterile vial. For laboratory research use only.
Products listed are intended for research purposes only.
| Trust Grade | Action | |||
|---|---|---|---|---|
Liberty Peptideswc_32339 | X | $70.00Best Price $14.00/mg | In Stock | Buy |
Polaris Peptideswc_16696 | D | $75.00 $75.00/mg | In Stock | Buy |
EZ Peptideswc_30349 | X | $78.00 $78.00/mg | In Stock | Buy |
Hydro Researchwc_10016760 | D | $80.00 $80.00/mg | Out of Stock | Buy |
Glow Aminoswc_13283 | D | $80.00 $80.00/mg | In Stock | Buy |
Peptirawc_121454 | D | $89.00 $89.00/mg | In Stock | Buy |
Ameano Peptideswc_44636 | X | $95.00 $95.00/mg | In Stock | Buy |
Ruo Biowc_4744 | D | $98.00 $9.80/mg | In Stock | Buy |
Skye Peptideswc_20176 | D | $99.00 $99.00/mg | In Stock | Buy |
Wholesale Peptidewc_7131 | D | $99.99 $10.00/mg | In Stock | Buy |
Orbitrex Peptidewc_14123 | X | $99.99 $99.99/mg | In Stock | Buy |
Protide Healthwc_19616 | D | $110.00 $11.00/mg | Out of Stock | Buy |
Iron Mountain Labzwc_37891 | D | $113.98 $113.98/mg | Out of Stock | Buy |
Vigor Peptideswc_8446 | X | $115.00 $11.50/mg | In Stock | Buy |
NuScience Peptideswc_33103 | D | $149.99 $119.99 $15.00/mg | Out of Stock | Buy |
True Peptide Labswc_3915 | X | $120.00 $12.00/mg | In Stock | Buy |
Extreme Peptideswc_415789 | D | $149.99 $129.99 $15.00/mg | In Stock | Buy |
Pure Lab Peptideswc_14091 | D | $149.99 $149.99/mg | In Stock | Buy |
Genesis Peptideswc_9143 | D | $170.00 $170.00/mg | In Stock | Buy |
Genetic Peptidewc_130256 | D | $225.00 $200.00 $225.00/mg | In Stock | Buy |
NEXAPHwc_85967 | X | $378.00 $323.00 $378.00/mg | In Stock | Buy |
Bulk Supplywc_488 | D | $350.00 $35.00/mg | In Stock | Buy |
Royal Peptideswc_17645 | D | $560.00 $46.67/mg | Out of Stock | Buy |
Nextday Peptideswc_5249 | X | $930.00 $930.00/mg | In Stock | Buy |
Sign in to view price trends and track how prices change over time.
No reviews yet - be the first to review this product!
Survey of the 2026 anti-obesity peptide pipeline: retatrutide, mazdutide, survodutide, and CagriSema — mechanism differences, Phase 3 trials, and what comes after tirzepatide in obesity research.
Read articleOxyntomodulin is the endogenous proglucagon-derived dual agonist of GLP-1R and GCGR, reducing appetite and boosting energy expenditure in preclinical and…
Read articleComprehensive research profile of survodutide (BI 456906), the novel dual GLP-1/glucagon receptor agonist in Phase 3 trials for obesity and MASH.